These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13310637)

  • 21. Preclinical testing of a vaccine candidate against tularemia.
    Suresh RV; Ma Z; Sunagar R; Bhatty V; Banik S; Catlett SV; Gosselin EJ; Malik M; Bakshi CS
    PLoS One; 2015; 10(4):e0124326. PubMed ID: 25897786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vaccination against tularemia in the monkeys.
    Tulis JJ; Eigelsbach HT; Hornick RB
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):893-7. PubMed ID: 4982863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tularemia ("rabbit plague")].
    Hassler D; Schwarz TF; Braun R
    Dtsch Med Wochenschr; 2003 Jan; 128(3):70. PubMed ID: 12596770
    [No Abstract]   [Full Text] [Related]  

  • 24. [History of vaccination against tularemia].
    SIL'CHENKO VS
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Oct; (10):83-9. PubMed ID: 13282489
    [No Abstract]   [Full Text] [Related]  

  • 25. Tularemia vaccines.
    Putzova D; Senitkova I; Stulik J
    Folia Microbiol (Praha); 2016 Nov; 61(6):495-504. PubMed ID: 27194547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Supplementary studies on Bacterium tularense in laboratory animals. VIII. Immunization experiments on rabbits].
    SATO K; OKADA K; KIKUTA K
    Nihon Saikingaku Zasshi; 1962 Feb; 17():107-11. PubMed ID: 14497417
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of the tularemia prevention measures in the natural foci of the Carpathian region].
    Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG
    Vrach Delo; 1980 Jan; (1):107-9. PubMed ID: 7376572
    [No Abstract]   [Full Text] [Related]  

  • 28. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 29. Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits.
    BELL JF; OWEN CR; LARSON CL
    J Infect Dis; 1955; 97(2):162-6. PubMed ID: 13263645
    [No Abstract]   [Full Text] [Related]  

  • 30. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Sunagar R; Kumar S; Franz BJ; Gosselin EJ
    Vaccine; 2016 Jun; 34(29):3396-404. PubMed ID: 27182819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress, challenges, and opportunities in Francisella vaccine development.
    Elkins KL; Kurtz SL; De Pascalis R
    Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of scarlet fever with vaccination against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():105-6. PubMed ID: 14349283
    [No Abstract]   [Full Text] [Related]  

  • 35. [Supplementary studies on Bacterium tularense in laboratory animals. VII. Immunization experiments with guinea pigs].
    SATO K; OKADA K; KIKUTA K
    Nihon Saikingaku Zasshi; 1962 Jan; 17():20-7. PubMed ID: 14497416
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on pathogenesis and immunity in tularemia; immunogenic properties for the white mouse of various strains of Bacterium tularense.
    DOWNS CM; WOODWARD JM
    J Immunol; 1949 Oct; 63(2):147-63. PubMed ID: 15390504
    [No Abstract]   [Full Text] [Related]  

  • 37. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.
    De Pascalis R; Mittereder L; Kennett NJ; Elkins KL
    Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Francisella tularensis vaccines.
    Oyston PC
    Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines against Francisella tularensis--past, present and future.
    Conlan JW
    Expert Rev Vaccines; 2004 Jun; 3(3):307-14. PubMed ID: 15176947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.
    Fuller CL; Brittingham KC; Porter MW; Hepburn MJ; Petitt PL; Pittman PR; Bavari S
    Mol Immunol; 2007 May; 44(12):3173-84. PubMed ID: 17349694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.